ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,002 | +881.4% | 2,232 | +2249.5% | 0.00% | – |
| Q2 2023 | $204 | +10.3% | 95 | 0.0% | 0.00% | – |
| Q1 2023 | $185 | -94.6% | 95 | -89.4% | 0.00% | – |
| Q4 2022 | $3,456 | -13.6% | 900 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | +100.0% | 900 | +800.0% | 0.00% | – |
| Q4 2021 | $2,000 | -60.0% | 100 | -50.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -61.5% | 200 | -50.0% | 0.00% | – |
| Q4 2020 | $13,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 5,402,041 | $4,845,631 | 1.54% |
| Sio Capital Management, LLC | 3,294,534 | $2,955,197 | 0.92% |
| Redmile Group, LLC | 14,178,045 | $12,717,706 | 0.60% |
| AlphaCentric Advisors LLC | 1,068,468 | $958,416 | 0.54% |
| Vantage Consulting Group Inc | 850,737 | $763,111 | 0.51% |
| Blue Owl Capital Holdings LP | 733,568 | $654,489 | 0.51% |
| Affinity Asset Advisors, LLC | 1,100,000 | $986,700 | 0.28% |
| Frazier Life Sciences Management, L.P. | 1,647,030 | $1,477,386 | 0.10% |
| Indie Asset Partners, LLC | 92,700 | $83,152 | 0.08% |
| GCM Grosvenor Holdings, LLC | 410,888 | $368,567 | 0.07% |